167 related articles for article (PubMed ID: 11754898)
1. Stimulation and inhibition of angiogenesis in diabetic retinopathy.
Funatsu H; Yamashita H; Noma H; Shimizu E; Yamashita T; Hori S
Jpn J Ophthalmol; 2001; 45(6):577-84. PubMed ID: 11754898
[TBL] [Abstract][Full Text] [Related]
2. Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin.
Noma H; Funatsu H; Yamashita H; Kitano S; Mishima HK; Hori S
Arch Ophthalmol; 2002 Aug; 120(8):1075-80. PubMed ID: 12149062
[TBL] [Abstract][Full Text] [Related]
3. Outcome of vitreous surgery and the balance between vascular endothelial growth factor and endostatin.
Funatsu H; Yamashita H; Noma H; Mochizuki H; Mimura T; Ikeda T; Hori S
Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1042-7. PubMed ID: 12601027
[TBL] [Abstract][Full Text] [Related]
4. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy.
Ogata N; Nishikawa M; Nishimura T; Mitsuma Y; Matsumura M
Am J Ophthalmol; 2002 Sep; 134(3):348-53. PubMed ID: 12208245
[TBL] [Abstract][Full Text] [Related]
5. Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
Simó R; Lecube A; Segura RM; García Arumí J; Hernández C
Am J Ophthalmol; 2002 Sep; 134(3):376-82. PubMed ID: 12208249
[TBL] [Abstract][Full Text] [Related]
6. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
Ambati J; Chalam KV; Chawla DK; D'Angio CT; Guillet EG; Rose SJ; Vanderlinde RE; Ambati BK
Arch Ophthalmol; 1997 Sep; 115(9):1161-6. PubMed ID: 9298058
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic shift in vitreous after vitrectomy in patients with proliferative diabetic retinopathy.
Yoshida S; Nakama T; Ishikawa K; Arima M; Tachibana T; Nakao S; Sassa Y; Yasuda M; Enaida H; Oshima Y; Kono T; Ishibashi T
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6997-7003. PubMed ID: 22977138
[TBL] [Abstract][Full Text] [Related]
8. Relation of diabetic macular edema to cytokines and posterior vitreous detachment.
Funatsu H; Yamashita H; Ikeda T; Mimura T; Shimizu E; Hori S
Am J Ophthalmol; 2003 Mar; 135(3):321-7. PubMed ID: 12614749
[TBL] [Abstract][Full Text] [Related]
9. Vitreous concentrations of TPA and plasminogen activator inhibitor are associated with VEGF in proliferative diabetic vitreoretinopathy.
Hattenbach LO; Allers A; Gümbel HO; Scharrer I; Koch FH
Retina; 1999; 19(5):383-9. PubMed ID: 10546932
[TBL] [Abstract][Full Text] [Related]
10. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.
Adamis AP; Miller JW; Bernal MT; D'Amico DJ; Folkman J; Yeo TK; Yeo KT
Am J Ophthalmol; 1994 Oct; 118(4):445-50. PubMed ID: 7943121
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy.
Funatsu H; Yamashita H; Nakanishi Y; Hori S
Br J Ophthalmol; 2002 Mar; 86(3):311-5. PubMed ID: 11864890
[TBL] [Abstract][Full Text] [Related]
12. Non-paralleled increase of hepatocyte growth factor and vascular endothelial growth factor in the eyes with angiogenic and nonangiogenic fibroproliferation.
Umeda N; Ozaki H; Hayashi H; Kondo H; Uchida H; Oshima K
Ophthalmic Res; 2002; 34(1):43-7. PubMed ID: 11834884
[TBL] [Abstract][Full Text] [Related]
13. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
14. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.
Funatsu H; Yamashita H; Ikeda T; Mimura T; Eguchi S; Hori S
Ophthalmology; 2003 Sep; 110(9):1690-6. PubMed ID: 13129863
[TBL] [Abstract][Full Text] [Related]
15. [A comparative study of vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy].
Zhou H; Zhang H
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):247-50. PubMed ID: 10451953
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders.
Funatsu H; Yamashita H; Ikeda T; Nakanishi Y; Kitano S; Hori S
Am J Ophthalmol; 2002 Apr; 133(4):537-43. PubMed ID: 11931788
[TBL] [Abstract][Full Text] [Related]
18. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
[TBL] [Abstract][Full Text] [Related]
19. Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy.
Loukovaara S; Robciuc A; Holopainen JM; Lehti K; Pessi T; Liinamaa J; Kukkonen KT; Jauhiainen M; Koli K; Keski-Oja J; Immonen I
Acta Ophthalmol; 2013 Sep; 91(6):531-9. PubMed ID: 23106921
[TBL] [Abstract][Full Text] [Related]
20. Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
Deng J; Wu DZ; Gao R
Yan Ke Xue Bao; 1999 Mar; 15(1):17-21. PubMed ID: 12579655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
